Home Aminos Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, monosodium salt

Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, monosodium salt

CAS No.:
203787-91-1
Catalog Number:
AG00386Q
Molecular Formula:
C15H20NNaO4
Molecular Weight:
301.3134
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
98%(HPLC)
In Stock USA
United States
$144
- +
1g
98%(HPLC)
In Stock USA
United States
$390
- +
5g
98%(HPLC)
In Stock USA
United States
$1129
- +
Product Description
Catalog Number:
AG00386Q
Chemical Name:
Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, monosodium salt
CAS Number:
203787-91-1
Molecular Formula:
C15H20NNaO4
Molecular Weight:
301.3134
MDL Number:
MFCD00952954
IUPAC Name:
sodium;8-[(2-hydroxybenzoyl)amino]octanoate
InChI:
InChI=1S/C15H21NO4.Na/c17-13-9-6-5-8-12(13)15(20)16-11-7-3-1-2-4-10-14(18)19;/h5-6,8-9,17H,1-4,7,10-11H2,(H,16,20)(H,18,19);/q;+1/p-1
InChI Key:
UOENJXXSKABLJL-UHFFFAOYSA-M
SMILES:
[O-]C(=O)CCCCCCCNC(=O)c1ccccc1O.[Na+]
UNII:
1YTW0422YU
Properties
Complexity:
312  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
301.129g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
301.318g/mol
Monoisotopic Mass:
301.129g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
89.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC). Die Pharmazie 20120301
Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects. Clinical pharmacology and therapeutics 20091201
Peri- and postnatal developmental toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley rats. International journal of toxicology 20090101
Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats. International journal of toxicology 20090101
Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative. Pharmaceutical research 20080101
Modular polyketide synthases and cis double bond formation: establishment of activated cis-3-cyclohexylpropenoic acid as the diketide intermediate in phoslactomycin biosynthesis. Journal of the American Chemical Society 20070221
Promiscuous fatty acyl CoA ligases produce acyl-CoA and acyl-SNAC precursors for polyketide biosynthesis. Journal of the American Chemical Society 20050706
Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050601
Oral delivery of insulin with the eligen technology: mechanistic studies. Current drug delivery 20050401
[Effect of casein and protamine on the enzymatic degradation and the orally hypoglycemic action of insulin]. Yao xue xue bao = Acta pharmaceutica Sinica 20041001
A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects. Diabetic medicine : a journal of the British Diabetic Association 20040401
Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats. Journal of microencapsulation 20040201
[Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution]. Yao xue xue bao = Acta pharmaceutica Sinica 20031201
Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate. Pharmaceutical research 20020801
Properties